<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01906450</url>
  </required_header>
  <id_info>
    <org_study_id>CL1688</org_study_id>
    <nct_id>NCT01906450</nct_id>
  </id_info>
  <brief_title>STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER HIGH SENSITIVE C-REACTIVE PROTEIN. RANDOMIZED CONTROLLED CLINICAL TRIAL.</brief_title>
  <official_title>STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER HIGH SENSITIVE C-REACTIVE PROTEIN. RANDOMIZED CONTROLLED CLINICAL TRIAL.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad del Valle, Colombia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad del Valle, Colombia</source>
  <brief_summary>
    <textblock>
      Human periodontitis is a group of highly prevalent oral inflammatory diseases and infections
      with relatively easy treatment and preventive features. The present study is aimed to
      determine if treating human individuals with chronic periodontitis, along with the use of
      antibiotics, reduces cardiovascular risk marker (HsPCR) and also intends to identify if
      severity of periodontitis could be associated with a raise of systemic inflammatory
      biomarkers on baseline.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">January 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER HIGH SENSITIVE C-REACTIVE PROTEIN.</measure>
    <time_frame>3 months</time_frame>
    <description>High sensitive C reactive protein - hs-PCR levels evaluate the effect of periodontal therapy alone or with azithromycin on levels of high sensitivity C-reactive protein (hs CRP) in patients with chronic periodontitis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER LIPIDIC PROFILE</measure>
    <time_frame>3 months</time_frame>
    <description>evaluate the effect of periodontal therapy alone or with azithromycin on levels of profile lipidic (Total cholesterol, triglycerides, HDL, LDL) in patients with chronic periodontitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER GLYCEMIA LEVELS</measure>
    <time_frame>3 months</time_frame>
    <description>evaluate the effect of periodontal therapy alone or with azithromycin on levels of glycemia in patients with chronic periodontitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER BLOOD BIOCHEMISTRY</measure>
    <time_frame>3 MONTHS</time_frame>
    <description>evaluate the effect of periodontal therapy alone or with azithromycin on blood biochemistry (arterial index, hemogram) in patients with chronic periodontitis.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER PERIODONTAL PARAMETERS</measure>
    <time_frame>3 months</time_frame>
    <description>evaluate the effect of periodontal therapy alone or with azithromycin on periodontal parameters (probing deep, bleeding on probing, clinical atachment level) in patients with chronic periodontitis.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Chronic Periodontitis</condition>
  <arm_group>
    <arm_group_label>Scaling and root planing plus Azithromycin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single session of scaling and root planning. Azithromycin tablets 500mg, 1 tablet every 24 hours for 5 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Scaling and root planing plus placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Single session of scaling and root planning placebo tablets 500mg, 1 tablet every 24 hours for 3 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>baselline screening only</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Dental prophylaxis is offered</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Scaling and root planing plus Azithromycin</intervention_name>
    <description>Single session of scaling and root planning using ultrasonic device. Azithromycin tablets 500mg, 1 tablet every 24 hours for 5 days</description>
    <arm_group_label>Scaling and root planing plus Azithromycin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Scaling and root planing plus placebo</intervention_name>
    <description>Single session of scaling and root planning placebo tablets 500mg, 1 tablet every 24 hours for 3 days</description>
    <arm_group_label>Scaling and root planing plus placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  must be of legal age (â‰¥ 18 years old)

          -  voluntary participation and signed information consent

          -  confirmed systemically healthy individual

          -  at least 15 teeth present in mouth

        Exclusion Criteria

          -  pregnant women

          -  smokers

          -  antibiotic consumption 6 months before inclusion

          -  HIV positive or AIDS

          -  Allergic reactions to macrolides and specifically to azithromycin

          -  Periodontal treatment 6 months before inclusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Universidad Del Valle</name>
      <address>
        <city>Cali</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Colombia</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 23, 2013</study_first_submitted>
  <study_first_submitted_qc>July 19, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 24, 2013</study_first_posted>
  <last_update_submitted>July 19, 2013</last_update_submitted>
  <last_update_submitted_qc>July 19, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 24, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad del Valle, Colombia</investigator_affiliation>
    <investigator_full_name>Jorge Enrique Soto</investigator_full_name>
    <investigator_title>periodontist Cert. DDS</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Chronic Periodontitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

